ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Hematology Oncology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 37

$1.58M Total Retail Price of All Prescriptions

Rank: 8 out of 37

882 Patients Receiving at Least One Drug in Part D
74% Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Mississippi
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

17% of this provider’s 882 patients filled at least one prescription for a schedule two drug, compared to an average of 17%.

Schedule Three
Controlled Substances

20% of this provider’s 882 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 17%.

Prescription Price

$157 was the average price of a prescription from this provider, compared to $474 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 699 450 178 S3 1 1
GABAPENTIN 574 426 156 2 5
ANASTROZOLE 532 478 87 3 2
TAMOXIFEN CITRATE 412 327 75 10 4 4
CIPROFLOXACIN HCL 286 195 156 5 18
MORPHINE SULFATE ER 256 103 78 S2 6 10
VENLAFAXINE HCL ER 247 211 44 7 23
POTASSIUM CHLORIDE 245 197 62 8 17
LEVOTHYROXINE SODIUM 236 182 39 9 19
ALPRAZOLAM 223 152 52 B 10 11
PANTOPRAZOLE SODIUM 202 152 56 11 32
ONDANSETRON HCL* 202 143 96 11 8
PREDNISONE 196 166 80 13 7
ZOLPIDEM TARTRATE 188 103 51 14 15
TRAZODONE HCL 153 110 41 15 36
FUROSEMIDE 144 103 44 16 21
MONTELUKAST SODIUM 141 122 39 17 38
EVISTA 139 99 25 18 27
WARFARIN SODIUM 137 96 30 19 6
OXYCODONE HCL-ACETAMINOPHEN 129 78 46 S2 20 22
LETROZOLE 113 80 19 21 3
TRIAMTERENE-HCTZ 113 87 31 21 30
MEGESTROL ACETATE 113 94 52 R 21 20
OMEPRAZOLE 107 81 26 24 13
TRAMADOL HCL 106 81 47 25 34
PROCHLORPERAZINE MALEATE 91 59 35 26 12
SPIRONOLACTONE 91 70 27 26 45
OXYCODONE-ACETAMINOPHEN 88 47 33 S2 28 46
DANAZOL 84 55 13 10 29 47
LISINOPRIL 83 57 15 30 48
AMLODIPINE BESYLATE 81 64 11 31 37
DEXAMETHASONE 80 51 36 32 9
FLUCONAZOLE 79 50 42 33 40
FENTANYL 78 52 29 S2 34 25
ATENOLOL 77 64 16 35 49
CITALOPRAM HBR 77 49 14 35 31
NIZATIDINE 73 54 14 37 50
HYDROCHLOROTHIAZIDE 71 49 16 38 51
CEFUROXIME 68 52 40 39 52
PROMETHAZINE HCL 66 28 30 R 40 41
NEXIUM 62 45 11 41 28
IMIPRAMINE HCL 61 61 12 R 42 61
PROAIR HFA 61 24 25 42 61
LORAZEPAM 58 44 22 B 44 26
ALENDRONATE SODIUM 58 53* 11 44 63
METRONIDAZOLE 53 41 33 46 65
METOPROLOL SUCCINATE 52 <11 <11 47 66
THALOMID 52 <11 <11 10 47 66
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 35 27 49 43
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.